PONTE VEDRA, Fla., Jan. 24, 2024 /PRNewswire/ Cadrenal Therapeutics, Inc., , a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant designed to.
PHOENIX, Jan. 23, 2024 /PRNewswire/ SenesTech, Inc. today announced that Joel Fruendt, Chief Executive Officer, and Tom Chesterman, Chief Financial Officer, will participate in a fireside chat.
LONGMONT, Colo., Jan. 23, 2024 /PRNewswire/ S&W Seed Company announced today that Mark Herrmann, CEO, will participate in a fireside chat and host one-on-one meetings with investors at the.
BALLERUP, Denmark, Jan. 23, 2024 /PRNewswire/ LiqTech International, Inc. , a clean technology company that manufactures and markets highly specialized filtration technologies, will participate.
/PRNewswire/ Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving.